- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 53,803,111
- Total 13F shares
- 1,428
- Share change
- +34
- Total reported value
- $54,692
- Price per share
- $38.30
- Number of holders
- 4
- Value change
- +$1,302
- Number of buys
- 1
Quarterly Holders Quick Answers
What is CUSIP 90240B106?
CUSIP 90240B106 identifies TYRA - Tyra Biosciences, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 90240B106:
Top shareholders of TYRA - Tyra Biosciences, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
3/4/5
13F
|
Director, 10%+ Owner · Company |
21%
|
12,266,575
|
$380,263,825 | +$11,370,397 | 04 Mar 2026 | |
| FMR LLC |
13D/G
13F
|
Company |
14%
|
7,747,648
|
$296,738,016 | +$231,353,566 | 31 Mar 2026 | |
| Boxer Capital Management, LLC |
3/4/5
|
Other* |
—
mixed-class rows
|
7,153,639
mixed-class rows
|
$125,264,455 | — | 18 Oct 2024 | |
| Nina S. Kjellson |
3/4/5
|
Director |
—
mixed-class rows
|
7,975,964
mixed-class rows
|
$122,459,032 | — | 05 Feb 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
7.5%
|
4,055,861
|
$106,628,586 | — | 31 Dec 2025 | |
| Alta Partners Management Company, L.P. |
13F
|
Company |
7.1%
|
3,823,425
|
$100,517,843 | — | 31 Dec 2025 | |
| Robert J. More |
3/4/5
|
Director |
—
mixed-class rows
|
3,845,625
mixed-class rows
|
$95,585,625 | -$5,250,026 | 19 Dec 2025 | |
| Boxer Capital, LLC |
3/4/5
|
Other* |
—
mixed-class rows
|
7,239,578
mixed-class rows
|
$94,186,205 | — | 06 Feb 2024 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
5.6%
|
2,984,818
|
$93,723,285 | $0 | 12 Feb 2026 | |
| Canaan XI L.P. |
13D/G
3/4/5
|
10%+ Owner |
5.5%
|
2,930,444
|
$88,938,975 | -$24,301,882 | 31 Dec 2025 | |
| Commodore Capital LP |
13F
13D/G
|
Company |
6.3%
from 13D/G
|
3,375,000
|
$88,728,750 | — | 31 Dec 2025 | |
| Canaan Partners XI LLC |
13F
|
Company |
6.3%
|
3,374,329
|
$88,711,109 | — | 31 Dec 2025 | |
| Todd Harris |
13D/G
3/4/5
|
President and CEO, Director |
5.1%
|
2,814,379
|
$85,416,403 | $0 | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
5.4%
from 13D/G
|
2,935,442
|
$77,084,707 | — | 31 Dec 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
5.4%
|
2,898,103
|
$76,191,128 | — | 31 Dec 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
4%
|
2,127,665
|
$64,574,633 | -$55,131,655 | 31 Dec 2025 | |
| Vestal Point Capital, LP |
13F
13D/G
|
Company |
4.5%
from 13D/G
|
2,425,000
|
$63,753,250 | — | 31 Dec 2025 | |
| BVF INC/IL |
13F
|
Company |
4%
|
2,127,665
|
$55,936,313 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.9%
|
2,086,423
|
$54,852,060 | — | 31 Dec 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.8%
|
2,066,818
|
$54,336,645 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
1,572,785
|
$41,348,518 | — | 31 Dec 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.9%
|
1,564,492
|
$41,130,495 | — | 31 Dec 2025 | |
| TCG Crossover GP I, LLC |
13D/G
|
— |
5.7%
|
2,898,103
|
$29,792,499 | $0 | 27 Feb 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.9%
|
1,029,298
|
$27,060,244 | — | 31 Dec 2025 | |
| Alta Partners NextGen Fund II Management, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,080,296
|
$26,844,267 | — | 17 Sep 2021 | |
| Caligan Partners LP |
13F
|
Company |
1.8%
|
944,257
|
$24,824,517 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.6%
|
874,192
|
$22,982,508 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.5%
|
818,326
|
$21,513,791 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
749,463
|
$19,703,382 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.3%
|
711,891
|
$18,715,614 | — | 31 Dec 2025 | |
| Trails Edge Capital Partners, LP |
13F
|
Company |
1.3%
|
700,000
|
$18,403,000 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
657,756
|
$17,296,136 | — | 31 Dec 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.98%
|
526,002
|
$13,828,593 | — | 31 Dec 2025 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.74%
|
398,482
|
$10,476,092 | — | 31 Dec 2025 | |
| Elmind Capital, LP |
13F
|
Company |
0.65%
|
350,000
|
$9,201,500 | — | 31 Dec 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.52%
|
278,564
|
$7,323,448 | — | 31 Dec 2025 | |
| Cormorant Asset Management, LP |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
1,069,932
|
$7,039,083 | — | 17 Sep 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
221,177
|
$5,814,743 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.39%
|
210,000
|
$5,520,900 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
200,956
|
$5,283,134 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
199,426
|
$5,242,910 | — | 31 Dec 2025 | |
| Daniel Bensen |
3/4/5
|
Chief Discovery Officer |
—
mixed-class rows
|
316,981
mixed-class rows
|
$4,904,256 | -$4,811,300 | 12 Feb 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
182,387
|
$4,794,954 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.32%
|
170,032
|
$4,470,141 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.24%
|
129,779
|
$3,412,000 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.24%
|
129,753
|
$3,411,206 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.24%
|
129,435
|
$3,402,846 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.23%
|
125,000
|
$3,286,250 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.22%
|
120,278
|
$3,162,109 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.22%
|
118,898
|
$3,125,827 | — | 31 Dec 2025 |
Institutional Holders of Tyra Biosciences, Inc. - COMMON STOCK (TYRA) as of Q1 2026
As of 31 Mar 2026,
Tyra Biosciences, Inc. - COMMON STOCK (TYRA) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,428 shares.
The largest 4 holders included
Versant Capital Management, Inc, GAMMA Investing LLC, Farther Finance Advisors, LLC, and SIGNATUREFD, LLC.
This page lists
4
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
133
Q1 2026 holders
4
Holder diff
-129
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.